Читать книгу Pathy's Principles and Practice of Geriatric Medicine - Группа авторов - Страница 51

1 1 Olshansky SJ, Carnes BA. Ever since Gompertz. Demography. 1997; 34(1):1–15.

2 2 Ruby JG, Smith M, Buffenstein R. Naked mole‐rat mortality rates defy gompertzian laws by not increasing with age. eLife. 2018; 7.

3 3 Mueller LD, Rose MR. Evolutionary theory predicts late‐life mortality plateaus. Proc Natl Acad Sci. 1996; 93(26):15249–15253.

4 4 Gavrilov LA, Gavrilova NS. Late‐life mortality is underestimated because of data errors. PLOS Biol. 2019; 17(2):e3000148.

5 5 Fries J. Aging, natural death, and the compression of morbidity. N Engl J Med. 1980; 303(3):130–135.

6 6 Rowe JW, Kahn RL. Human aging: usual and successful. Science. 1987; 237(4811):143–149.

7 7 Kaeberlein M, Rabinovitch PS, Martin GM. Healthy aging: The ultimate preventative medicine. Science. 2015; 350(6265):1191–1193.

8 8 Bergman RAM. Who is old?: Death rate in a Japanese concentration camp as a criterion of age. J Gerontol. 1948; 3(1):14–17.

9 9 Schrödinger E. What Is Life? The Physical Aspect of the Living Cell; With Mind and Matter; & Autobiographical Sketches. Cambridge University Press; 1992

10 10 Medawar P. An unsolved problem of biology. University College, London; 1952.

11 11 Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 1957; 11(4):398–411.

12 12 Hamilton WD. The moulding of senescence by natural selection. J Theor Biol. 1966; 12(1):12–45.

13 13 Charlesworth B. Evolution in Age‐Structured Populations, Cambridge University Press; 1994.

14 14 Kirkwood TB. Evolution of ageing. Nature. 1977; 270(5635):301–304.

15 15 López‐Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013; 153(6):1194–1217.

16 16 Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking aging to chronic disease. Cell 2014; 159(4):709–713.

17 17 Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2019; 361(15):1475–1485.

18 18 Moskalev AA, Shaposhnikov MV, Plyusnina EN, et al. The role of DNA damage and repair in aging through the prism of Koch‐like criteria. Ageing Res Rev. 2013; 12(2):661–684.

19 19 Park CB, Larsson N‐G. Mitochondrial DNA mutations in disease and aging. J Cell Biol. 2011; 193(5):809–818.

20 20 Baker DJ, Dawlaty MM, Wijshake T, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2013; 15(1):96–102.

21 21 Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961; 25(3):585–621.

22 22 Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol. 2007; 3(10):640–649.

23 23 Armanios M, Alder JK, Parry EM, Karim B, Strong MA, Greider CW. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet. 2009; 85(6):823–832.

24 24 Tomás‐Loba A, Flores I, Fernández‐Marcos PJ, et al. Telomerase reverse transcriptase delays aging in cancer‐resistant mice. Cell 2008; 135(4):609–622.

25 25 Wang Q, Zhan Y, Pedersen NL, Fang F, Hägg S. Telomere length and all‐cause mortality: a meta‐analysis. Ageing Res Rev. 2018; 48:11–20.

26 26 Blackburn EH, Epel ES, Lin J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2015; 350(6265):1193–1198.

27 27 Ferrucci L, Gonzalez‐Freire M, Fabbri E, et al. Measuring biological aging in humans: A quest. Aging Cell. 2019; 19(2):e13080.

28 28 Hannum G, Guinney J, Zhao L, et al. Genome‐wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013; 49(2):359–367.

29 29 Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013; 14(10):3156.

30 30 Marioni RE, Shah S, McRae AF, et al. The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936. Int J Epidemiol. 2015; 44(4):1388–1396.

31 31 Marioni RE, Shah S, McRae AF, et al. DNA methylation age of blood predicts all‐cause mortality in later life. Genome Biol. 2015; 16:25.

32 32 Horvath S, Raj K. DNA methylation‐based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018; 19(6):371–384.

33 33 Field AE, Robertson NA, Wang T, Havas A, Ideker T, Adams PD. DNA methylation clocks in aging: categories, causes, and consequences. Mol Cell. 2018; 71(6):882–895.

34 34 Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11(3):298–300.

35 35 Hekimi S, Lapointe J, Wen Y. Taking a ‘good’ look at free radicals in the aging process. Trends Cell Biol. 2011; 21(10):569–576.

36 36 Zane AC, Reiter DA, Shardell M, et al. Muscle strength mediates the relationship between mitochondrial energetics and walking performance. Aging Cell. 2017; 16(3):461–468.

37 37 Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE. Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem. 2009; 78:959–991.

38 38 Koga H, Kaushik S, Cuervo AM. Protein homeostasis and aging: The importance of exquisite quality control. Ageing Res Rev. 2011; 10(2):205–215.

39 39 Min J‐N, Whaley RA, Sharpless NE, Lockyer P, Portbury AL, Patterson C. CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol Cell Biol. 2008; 28(12):4018–4025.

40 40 Hansen M, Rubinsztein DC, Walker DW. Autophagy as a promoter of longevity: insights from model organisms. Nat Rev Mol Cell Biol. 2018; 19(9):579–593.

41 41 Barzilai N, Huffman DM, Muzumdar RH, Bartke A. The critical role of metabolic pathways in aging. Diabetes. 2012; 61(6):1315–1322.

42 42 Singh PP, Demmitt BA, Nath RD, Brunet A. The genetics of aging: a vertebrate perspective. Cell. 2019; 177(1):200–220.

43 43 Garinis GA, van der Horst GTJ, Vijg J, Hoeijmakers JHJ. DNA damage and ageing: new‐age ideas for an age‐old problem. Nat Cell Biol. 2008; 10(11):1241–1247.

44 44 Fontana L, Partridge L, Longo VD.Extending healthy life span – from yeast to humans. Science. 2010; 328(5976):321–326.

45 45 Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460(7253):392–395.

46 46 Justice JN, Ferrucci L, Newman AB, et al.A framework for selection of blood‐based biomarkers for geroscience‐guided clinical trials: report from the TAME Biomarkers Workgroup. GeroScience. 2018; 40(5–6):419–436.

47 47 Coppé J‐P, Desprez P‐Y, Krtolica A, Campisi J. The senescence‐associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010; 5:99–118.

48 48 van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509(7501):439–446.

49 49 Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007; 130(2):223–233.

50 50 Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004; 114(9):1299–1307.

51 51 Ressler S, Bartkova J, Niederegger H, et al. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell. 2006; 5(5):379–389.

52 52 Jeck WR, Siebold AP, Sharpless NE. Review: a meta‐analysis of GWAS and age‐associated diseases. Aging Cell. 2012; 11(5):727–731.

53 53 Justice JN, Gregory H, Tchkonia T, et al. Cellular senescence biomarker p16INK4a+ cell burden in thigh adipose is associated with poor physical function in older women. J Gerontol Ser A. 2017; 73(7):939–945.

54 54 Matheu A, Maraver A, Klatt P, et al. Delayed ageing through damage protection by the Arf/p53 pathway. Nature. 2007; 448(7151):375–379.

55 55 Matheu A, Maraver A, Collado M, et al. Anti‐aging activity of the Ink4/Arf locus. Aging Cell. 2009; 8(2):152–161.

56 56 Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a‐positive senescent cells delays ageing‐associated disorders. Nature. 2011; 479(7372):232–236.

57 57 Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16(Ink4a)‐positive cells shorten healthy lifespan. Nature. 2016; 530(7589):184–189.

58 58 van Deursen JM. Senolytic therapies for healthy longevity. Science. 2019; 364(6441):636–637.

59 59 Sahin E, Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010; 464(7288):520–528.

60 60 Lavasani M, Robinson AR, Lu A, et al. Muscle‐derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat Commun. 2012; 3:608.

61 61 Franceschi C, Bonafè M. Centenarians as a model for healthy aging. Biochem Soc Trans. 2003; 31(2):457–461.

62 62 Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019; 25(12):1822–1832.

63 63 Ferrucci L, Fabbri E. Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 15(9):505‐522.

64 64 Youm Y‐H, Kanneganti T‐D, Vandanmagsar B, et al. The NLRP3 Inflammasome promotes age‐related thymic demise and immunosenescence. Cell Rep. 2012; 1(1):56–68.

65 65 Youm Y‐H, Grant RW, McCabe LR, et al. Canonical Nlrp3 inflammasome links systemic low‐grade inflammation to functional decline in aging. Cell Metab. 2013; 18(4):519–532.

66 66 Heneka MT, Kummer MP, Stutz A, et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 2012; 493(7434):674–678.

67 67 Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017; 377(12):1119–1131.

68 68 Ridker PM, MacFadyen JG, Thuren T, et al. Effect of interleukin‐1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double‐blind, placebo‐controlled trial. Lancet. 2017; 390(10105):1833–1842.

69 69 Nikolich‐Žugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018; 19(1):10–19.

70 70 Fulop T, Dupuis G, Baehl S, et al. From inflamm‐aging to immune‐paralysis: a slippery slope during aging for immune‐adaptation. Biogerontology. 2016; 17(1):147–157.

71 71 Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age‐associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med. 2008; 205(3):711–723.

72 72 Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013; 14(5):428–436.

73 73 Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol Baltim Md 1950. 2002; 169(4):1984–1992.

74 74 Hadrup SR, Strindhall J, Køllgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus‐specific T cells in the very elderly. J Immunol Baltim Md 1950. 2006; 176(4):2645–2653.

75 75 Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. Nature. 2018; 561(7721):45–56.

76 76 Newman JC, Sokoloski JL, Robbins PD, et al. Creating the next generation of translational geroscientists. J Am Geriatr Soc. 2019; 67(9):1934–1939.

77 77 Guerville F, De Souto Barreto P, Ader I, et al. Revisiting the hallmarks of aging to identify markers of biological age. J Prev Alzheimers Dis. 2020; 7(1):56–64.

78 78 Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013; 381(9868):752–762.

79 79 Cesari M, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, et al. Evidence for the domains supporting the construct of intrinsic capacity. J Gerontol Ser A. 2018; 73(12):1653–1660.

80 80 Duggal NA, Niemiro G, Harridge SDR, Simpson RJ, Lord JM. Can physical activity ameliorate immunosenescence and thereby reduce age‐related multimorbidity? Nat Rev Immunol. 2019; 19(9):563–572.

81 81 Gensous N, Garagnani P, Santoro A, et al. One‐year Mediterranean diet promotes epigenetic rejuvenation with country‐ and sex‐specific effects: a pilot study from the NU‐AGE project. GeroScience. 2020; 42(2):687‐701